PRUEBA PARA LA DETERMINACIÓN DE LA LIPOCALINA ASOCIADA A LA GELATINASA DE NEUTRÓFILOS
Mexico·Clase I·III. Agentes de diagnóstico·PRODUCTOS ROCHE,
S.A. DE C.V.·Registered November 17, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- NGAL TEST
- Trade Name (English)
- NGAL TEST
- Analysis ID
- 1436R2022 SSA
- Registration Date
- November 17, 2022
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA PARA LA DETERMINACIÓN DE LA LIPOCALINA ASOCIADA A LA GELATINASA DE NEUTRÓFILOS (PRUEBA PARA LA DETERMINACIÓN DE LA LIPOCALINA ASOCIADA A LA GELATINASA DE NEUTRÓFILOS) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1436R2022 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on November 17, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.